Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
—·2d
Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.
ChannelsstocksCountriesusaCategoriesanalyst-ratings
Open original source ↗Published
6/8/2026, 10:16:00 AM
Fetched
6/8/2026, 12:07:17 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
en